Evidence map›Paper›PMID 38868605›Full record

ReviewGlobal challenges (Hoboken, NJ)2024

Updates on Hydrogen Value Chain: A Strategic Roadmap.

Julio Garcia-Navarro, Mark A Isaacs, Marco Favaro, Dan Ren, Wee-Jun Ong, Michael Grätzel, Pablo Jiménez-Calvo

Abstract readReview
In one paragraph

Review in Global challenges (Hoboken, NJ), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Updates on Hydrogen Value Chain: A Strategic Roadmap.Global challenges (Hoboken, NJ) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Julio Garcia-NavarroStichting New Energy Coalition Nijenborgh 6 Groningen 9747 AG The Netherlands.
Mark A IsaacsDepartment of Chemistry University College London 20 Gower Street London WC1H 0AJ UK.
Marco FavaroInstitute for Solar Fuels Helmholtz-Zentrum Berlin für Materialien und Energy GmbH Hahn-Meitner-Platz 1 14109 Berlin Germany.
Dan RenSchool of Chemical Engineering and Technology Xi'an Jiaotong University West Xianning Road 28 Xi'an 710049 China.
Wee-Jun OngSchool of Energy and Chemical Engineering Xiamen University Malaysia Darul Ehsan Selangor 43900 Malaysia.
Michael GrätzelLaboratory of Photonics and Interfaces Institute of Chemical Sciences and Engineering École Polytechnique Fédérale de Lausanne (EPFL) Lausanne 1015 Switzerland.
Pablo Jiménez-CalvoDepartment of Colloid Chemistry Max-Planck-Institute of Colloids and Interfaces Am Mühlenberg 1 14476 Potsdam Germany.ORCID https://orcid.org/0000-0002-9826-6995

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A strategic roadmap for noncarbonized fuels is a global priority, and the reduction of carbon dioxide emissions is a key focus of the Paris Agreement to mitigate the effects of rising temperatures. In this context, hydrogen is a promising noncarbonized fuel, but the pace of its implementation will depend on the engineering advancements made at each step of its value chain. To accelerate its adoption, various applications of hydrogen across industries, transport, power, and building sectors have been identified, where it can be used as a feedstock, fuel, or energy carrier and storage. However, widespread usage of hydrogen will depend on its political, industrial, and social acceptance. It is essential to carefully assess the hydrogen value chain and compare it with existing solar technologies. The major challenge to widespread adoption of hydrogen is its cost as outlined in the roadmap for hydrogen. It needs to be produced at the levelized cost of hydrogen of less than $2 kg

Indexed as

consumptionhydrogenproductionstoragetransportvalue chain

Identifiers

PMID38868605
PMCPMC11165467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.